Symptom Burden and Unmet Supportive Care Needs in Lung Cancer Patients Undergoing First or Second Line Immunotherapy

Completed

Conditions studied: Lung Neoplasm

In brief

Doctors are recruiting patients receiving care for lung cancer at the Wake Forest Baptist Comprehensive Cancer Center asking about needs and experiences during immunotherapy. Immunotherapy is a new treatment for lung cancer. The research is to better understand patients' perspectives on what immunotherapy is like and will provide important information to help understand the symptoms patients experience, the impact of treatment on daily life, ways that people adapt to the challenges of treatment, and services that may help people live better during treatment.

Key facts

Study ID

NCT03741868

Run by

Wake Forest University Health Sciences

People needed

60

Starts

2016-10-16

Expected to finish

2019-02-01

Last updated by the study team

2020-07-24

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histologically or cytologically confirmed stage IV (per AJCC 7th edition) non-small cell lung cancer.
• Receiving first or second line immunotherapy.
• ECOG Performance status of 0-3.
• English-speaking

You may not qualify if…

• Unable to provide informed consent

Where it is running

• Laurie E Steffen — Winston-Salem, North Carolina, United States
• Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.